KC expression of SPIC target genes such as Hmox1 was also decreased during NASH, suggesting that this loss of SPIC also led to less transcriptional activity at its target enhancers (Figure 3B). The gene discussed is CALCA; the disease is metabolic dysfunction-associated steatohepatitis.